ATNXQ — Athenex Share News
0.000.00%
Last trade - 00:00HealthcareHighly SpeculativeMicro Cap
- $0.13m
- $74.91m
- $102.82m
Athenex surges as oral use of breast cancer drug shows efficacy
Brief: Athenex Announces Quantum Leap Healthcare Collaborative Reports Positive Trial Result Of I-Spy2 Trial
Brief: Athenex Exits 503B Sterile Compounding Business
Athenex Inc reports results for the quarter ended in September - Earnings Summary
Brief: Athenex Announces Receipt Of Positive Nasdaq Listing Determination
Brief: Athenex Provides Third Quarter 2022 Financial Results
Athenex Inc expected to post a loss of 15 cents a share - Earnings Preview
Brief: Athenex Files Definitive Proxy Statement For Special Stockholder Meeting
U.S. STOCKS ON THE MOVE-Warby Parker, NV5 Global, Absci
U.S. STOCKS ON THE MOVE-Cyclacel, Major U.S. banks, Gold miners
U.S. STOCKS ON THE MOVE-Energy firms, WeWork, aTyr Pharma
U.S. STOCKS ON THE MOVE-Walt Disney, Coupang, crypto stocks
Athenex dives on $30 mln stock-and-warrants deal
Brief: Athenex Announces Pricing Of $30 Million Public Offering Of Common Stock And Warrants
Brief: Athenex Files For Offering Of Common Stock And Warrants
Brief: Athenex Inc Files For Mixed Shelf Offering Size Not Disclosed - SEC Filing
Brief: Athenex, Inc. Announces Proposed Underwritten Public Offering Of Common Stock And Warrants
Athenex Inc reports results for the quarter ended in June - Earnings Summary
Brief: Athenex Provides Second Quarter 2022 Financial Results